ABT-080 (VML-530) is a leukotriene synthesis inhibitor/FLAP inhibitor with the potential to be used for the treatment of asthma. Inhibiting ionophore-stimulated LTB(4) formation with with IC50 of 20 nM.

纯度：≥98%

CAS：189498-57-5